Clinical Trials Browser

Has results × NVP-BKM120 × Clear all

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Nasopharyngeal Neoplasms

Leukemia, Lymphocytic, Chronic, B-Cell

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

Prostatic Neoplasms

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Glioblastoma

Breast Neoplasms

Hypoxia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Advanced Endometrial Cancer

Brain Neoplasms, Glioblastoma

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Skin Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

Brain Neoplasms, Glioblastoma, Gliosarcoma

Lymphoma, Recurrence

Neoplasm Metastasis, Prostatic Neoplasms

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

Brain Neoplasms, Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck

LOGIC-2

Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia

A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas

STAR Cape+BKM120 MBC With Brain Met

PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Neoadjuvant BKM120 in High-risk Prostate Cancer

A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer

BELLE-2

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

NeoPHOEBE

BKM120

BKM120 as Second-line Therapy for Advanced Endometrial Cancer

Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma

Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib

BELLE-3

Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma

BKM120 For Triple Negative Breast Cancer

SIGNATURE

Safety and Efficacy of BKM120 in Relapsed and Refractory NHL

Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women

Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy

Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma

Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)

BKM120 in Metastatic Castration-resistant Prostate Cancer

BELLE-4

Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer

BASALT-1